Shirley Ryan AbilityLab
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Shirley Ryan AbilityLab sits in the top decile of US sponsors by registered trial count (#204 of 15,742 sponsors by registered trial count).
Shirley Ryan AbilityLab: 138 sponsored US clinical trials, 36 recruiting.
Shirley Ryan AbilityLab sponsors 138 registered US clinical trials on ClinicalTrials.gov, 36 of them currently recruiting, and 69 completed. 5 of these trials are in Phase 3-4 (later-stage) and 11 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 24 trials.
Top-decile sponsor footprint
Shirley Ryan AbilityLab ranks in the top decile of sponsors by registered trial count (#204 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
69 of 72 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (95.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
138 total, page 2 of 3
VR to Evaluate Phantom Limb Pain
NCT05915065
Personalized Mobility Interventions Using Smart Sensor Resources for Lower-Limb Prosthesis Users
NCT03930199
GaMA Metric to Quantify Functional Importance of Various Upper Limb Prosthetic Devices
NCT06420687
Robot Based Gait Training Therapy for Pediatric Population With Cerebral Palsy Using the CPWalker
NCT03937700
C-Brace II Spinal Cord Injury
NCT03930056
Wearable Sensors and Video Recordings to Monitor Motor Development
NCT03770832
Investigation Into an Innovative, Clinical Slip Inducing Device in the Chronic Incomplete Spinal Cord Population
NCT03744286
A Multi-Center Clinical Trial in Individuals With Spinal Cord Injury
NCT03644277
Wearable Airbag Technology to Mitigate Falls in Individuals With High Fall Risk
NCT05076565
Impact of Powered Knee-Ankle Prosthesis Leg on Everyday Community Mobility and Social Interaction
NCT03204513
Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis
NCT02089880
Mobility Training Using Exoskeletons for Functional Recovery After Stroke
NCT02128152
EKSO Trial: Powered Exoskeleton for Ambulation in Subjects With Spinal Cord Injury (SCI)
NCT01701388
Noninvasive Brain Stimulation to Enhance Cognition at Home Following a TBI.
NCT07428980
Neuromusculoskeletal Interface for Bionic Arms
NCT07032753
Improving Walking After Spinal Cord Injury
NCT07223710
Evaluation of Sensorimotor Ankle Impairments in Chronic Stroke
NCT06410989
Somatosensation Device Trial
NCT06168396
Enhanced Medical Rehabilitation for Spinal Cord Injury
NCT03952416
TMS for Investigating Memory Facilitation
NCT05462782
Effects of 4-AP on Functional SCI Recovery
NCT05447676
Safety and Feasibility of eGlove
NCT05345301
Acute Intermittent Hypoxia in Traumatic Brain Injury
NCT04890639
Assessing Visual Feedback of HR Monitoring in Rehabilitation - Pilot
NCT05273801
Self-Catheterization Mirror System for Female Patients
NCT05406258
Harmony Scapulohumeral Rhythm (SHR) Reliability and Efficacy Study
NCT05251077
Soft Exosuits for Functional Gait Recovery in Acute Stroke Rehabilitation
NCT06231511
Rewards Sensitivity After Brain Injury
NCT06510023
Comparison of Two High-intensity Gait Training Interventions on Contraversive Pushing Behaviors in Individuals Poststroke
NCT04550039
Sleep Quality, Heart Rate Variability and Anxiety Following Brain Injury
NCT04652895
Determining the Incidence of Vestibular Dysfunction in Traumatic Brain Injury Patients
NCT04592575
SCI Acute Intermittent Hypoxia and Non-Invasive Spinal Stimulation Combined With Gait Training
NCT03922802
Corticospinal Function After Spinal Cord Injury
NCT02451683
Resilience in Persons Following Spinal Cord Injury
NCT04544761
Modulating Intensity and Dosage of Aphasia Scripts
NCT04138940
Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms
NCT04393558
Effect of mCIMT Casting on Speech-language Outcomes in Children With Hemiparesis
NCT04259814
Implementing a CO-OP Group in the Day Rehab Setting: A Pilot Study.
NCT04246385
American Heart Association- Stroke/Hypoxia Study
NCT04019522
Lower Limb Function After Spinal Cord Injury
NCT02635893
Effect of a Novel Intervention Using Daily Intermittent Hypoxia and High Intensity Training on Upper Limb Function in Individuals With Spinal Cord Injury
NCT03643770
The Impact of Yoga-based Physical Therapy for Individuals With Traumatic Brain Injury
NCT03701594
Noninvasive Spinal Stimulation in Stroke
NCT03714282
Improving Electronic Written Communication in Aphasia
NCT03773419
Efficacy of Samsung GEMS-H Device Training in Older Adults
NCT05197127
Low Cost Socket for Lower Limb Amputees
NCT04725461
EMG Training for Altering Activation Patterns After Stroke
NCT03619772
Acute Intermittent Hypoxia in Persons With Multiple Sclerosis
NCT04280484
Functional Importance of a Powered Multifunction Wrist Protocol
NCT04069793
Supportive Wheelchair Back Compared to Fabric Back
NCT03962582
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 8 |
| Phase 2 | 3 |
| Phase 3 | 1 |
| Phase 4 | 4 |
What is open in the Shirley Ryan AbilityLab pipeline
36 recruiting of 138 indexed (26% open); 69 completed (50%).
Phase mix: 5 late (III/IV) vs 11 early (I/II) (early-phase heavy).
Top condition: Stroke (24 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Shirley Ryan AbilityLab: open-pipeline peers nationwide
Peers matched on 138 registered trials and 26% open enrollment, not the therapeutic-area sidebar.
Shirley Ryan AbilityLab sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 138 trials (± recruiting share)
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · 138 trials · 3% recruiting
- Barbara Ann Karmanos Cancer Institute · 139 trials · 12% recruiting
- Centers for Disease Control and Prevention · 139 trials · 2% recruiting
- Mclean Hospital · 140 trials · 19% recruiting
Sponsors near 26% open enrollment (± trial volume)
- University Health Network, Toronto · 26% recruiting · 23 trials
- Syracuse University · 26% recruiting · 31 trials
- Rutgers, The State University of New Jersey · 26% recruiting · 413 trials
- Hackensack Meridian Health · 26% recruiting · 90 trials
Related
What to do with this Shirley Ryan AbilityLab page
138 registered trials is a research-attention snapshot, not an endorsement of Shirley Ryan AbilityLab or any single study.
- 36 of Shirley Ryan AbilityLab's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition Shirley Ryan AbilityLab studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Shirley Ryan AbilityLab pipeline card: 138 registered trials from official public datasets.Report a data error.